Gene therapy trial aims to tame Parkinson's symptoms
NCT ID NCT06480461
First seen Apr 02, 2026 · Last updated May 18, 2026 · Updated 11 times
Summary
This early-stage study tests a gene therapy called VGN-R09b in 39 people with Parkinson's disease whose motor symptoms are not well controlled by current medications. The main goal is to check safety and tolerability, while also measuring changes in movement and daily function. The treatment is injected directly into the brain to potentially improve symptom control, but it is not expected to cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai
Shanghai, Shanghai Municipality, 200120, China
Conditions
Explore the condition pages connected to this study.